In an extension of that work, here we demonstrate that DCs loaded with killed allogeneic breast cancer cells can prime naïve CD8+ T cells to differentiate into tumor antigen specific CTLs by confirming their specificity for three known breast cancer antigens: cyclin B1, MUC-1, and survivin. This evidence concerns the gene BIRC5 and breast carcinoma.